338 Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli.
http://www.nature.com/ncomms/2016/160205/ncomms10390/full/ncomms10390.html
337 Gene editing via CRISPR-Cas9 restores dystrophin protein and improves muscle function in mouse models of muscular dystrophy.
http://science.sciencemag.org/content/351/6271/407
336 Development of a CRISPR/Cas9-based gene drive system in Anopheles gambiae, the main vector for the malaria parasite, paves the way for control of this pest insect.
http://www.nature.com/nbt/journal/v34/n1/abs/nbt.3439.html
335 Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
http://www.pnas.org/content/113/1/E16.abstract
334 A DNA-based system for selecting and displaying the combined result of two input variables.
http://www.nature.com/ncomms/2015/151208/ncomms10089/full/ncomms10089.html
333 Antibody-Modified Reduced Graphene Oxide Films with Extreme Sensitivity to Circulating Tumor Cells.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201502615/full
332 High-performance mussel-inspired adhesives of reduced complexity.
http://www.nature.com/ncomms/2015/151019/ncomms9663/full/ncomms9663.html
331 Direct optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophy.
http://www.nature.com/ncomms/2015/151013/ncomms9506/full/ncomms9506.html
330 CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation.
http://advances.sciencemag.org/content/1/7/e1500454
329 Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria.
http://www.nature.com/ncomms/2015/150827/ncomms9072/full/ncomms9072.html
|
